Literature DB >> 11016599

Immunoreactive domains and integrin-binding motifs in adenovirus penton base capsomer.

S S Hong1, M Bardy, M Monteil, B Gay, C Denesvre, J Tournier, G Martin, M Eloit, P Boulanger.   

Abstract

A panel of nine independent mouse monoclonal antibodies (MAbs) against penton base capsomers of subgenus C adenovirus serotypes 2 (Ad2) and 5 (Ad5) were isolated and characterized. Two of them (1D2 and 5A5), raised against Ad5 virion as the immunogen, bound to sodium dodecyl sulfate (SDS)-resistant and subgenus C-specific epitopes that were not present in subgenus B Ad3 penton base. The 1D2 and 5A5 epitopes were mapped to two distinct regions that did not belong to the main variable region carrying the integrin-binding RGD motif at position 340. For the other seven MAbs, raised against recombinant Ad2 penton base protein (9S-pentamers), the epitopes were sensitive to SDS-denaturation, but reacted with native Ad2, Ad5, and Ad3 penton base. The epitopes recognized by the nine MAbs and by polyclonal antipenton base antibodies defined three major immunoreactive regions. One (I) mapped to the N-terminal domain (residues 116-165); the other two regions were almost symmetrically disposed on both sides of the integrin-binding RGD motif at position 340, within residues 248-270 (II), and within residues 368-427 (III) in the C-terminal domain. Region II overlapped the fiber-binding site in penton base (residues 254-260). None of the MAbs showed any detectable virus neutralization effect, but they all slightly augmented the efficiency of Ad-mediated gene transfer. Although none of their epitopes included the RGD-340 tripeptide, substitutions of the arginine residue in the RGD motif abolished the reactivity of six individual and distant epitopes, suggesting a major conformational role for the RGD-containing domain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016599     DOI: 10.1089/08828240050144671

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  6 in total

1.  Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity.

Authors:  Anja Krause; Ju H Joh; Neil R Hackett; Peter W Roelvink; Joseph T Bruder; Thomas J Wickham; Imre Kovesdi; Ronald G Crystal; Stefan Worgall
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Directed evolution of mutator adenoviruses resistant to antibody neutralization.

Authors:  Nicolle D Myers; Ksenia V Skorohodova; Anshu P Gounder; Jason G Smith
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

3.  Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and d fibers.

Authors:  S Lecollinet; F Gavard; M J E Havenga; O B Spiller; A Lemckert; J Goudsmit; M Eloit; J Richardson
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Postentry neutralization of adenovirus type 5 by an antihexon antibody.

Authors:  Robin Varghese; Yeshi Mikyas; Phoebe L Stewart; Robert Ralston
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (addl1520) for treatment of liver tumors.

Authors:  Saw See Hong; Nagy A Habib; Laure Franqueville; Steen Jensen; Pierre A Boulanger
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport.

Authors:  Jason G Smith; Aurelia Cassany; Larry Gerace; Robert Ralston; Glen R Nemerow
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.